Biotech’s Bright Hopes
May 23, 2001 | Source: Washington Post
About 350 drugs are in late-stage clinical trials, but there are expensive hurdles to federal approval.
Cures for pulmonary hypertension, diabetic neuropathy, and some forms of cancer are among the possibilities.